Red Spruce Capital’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.31M | Sell |
44,749
-1,079
| -2% | -$200K | 3.6% | 4 |
|
|
2025
Q1 | $9.6M | Sell |
45,828
-6,997
| -13% | -$1.47M | 4.52% | 4 |
|
|
2024
Q4 | $9.39M | Buy |
52,825
+77
| +0.1% | +$13.7K | 4.17% | 3 |
|
|
2024
Q3 | $10.4M | Sell |
52,748
-748
| -1% | -$148K | 4.74% | 3 |
|
|
2024
Q2 | $9.18M | Buy |
53,496
+3,816
| +8% | +$655K | 4.26% | 4 |
|
|
2024
Q1 | $9.05M | Buy |
49,680
+62
| +0.1% | +$11.3K | 4.2% | 4 |
|
|
2023
Q4 | $7.69M | Buy |
49,618
+488
| +1% | +$75.6K | 3.95% | 3 |
|
|
2023
Q3 | $7.32M | Sell |
49,130
-22
| -0% | -$3.28K | 4.16% | 4 |
|
|
2023
Q2 | $6.62M | Buy |
49,152
+10,162
| +26% | +$1.37M | 3.57% | 5 |
|
|
2023
Q1 | $6.21M | Buy |
38,990
+261
| +0.7% | +$41.6K | 3.64% | 5 |
|
|
2022
Q4 | $6.26M | Sell |
38,729
-103
| -0.3% | -$16.6K | 3.98% | 4 |
|
|
2022
Q3 | $5.21M | Sell |
38,832
-2,627
| -6% | -$353K | 3.66% | 4 |
|
|
2022
Q2 | $6.35M | Sell |
41,459
-716
| -2% | -$110K | 4.23% | 4 |
|
|
2022
Q1 | $6.84M | Sell |
42,175
-550
| -1% | -$89.2K | 3.88% | 4 |
|
|
2021
Q4 | $5.79M | Buy |
42,725
+150
| +0.4% | +$20.3K | 3.16% | 4 |
|
|
2021
Q3 | $4.59M | Buy |
42,575
+564
| +1% | +$60.8K | 2.69% | 8 |
|
|
2021
Q2 | $4.73M | Sell |
42,011
-224
| -0.5% | -$25.2K | 2.79% | 7 |
|
|
2021
Q1 | $4.57M | Buy |
42,235
+990
| +2% | +$107K | 2.91% | 6 |
|
|
2020
Q4 | $4.42M | Buy |
41,245
+930
| +2% | +$99.6K | 3.07% | 5 |
|
|
2020
Q3 | $3.53M | Buy |
40,315
+123
| +0.3% | +$10.8K | 2.87% | 7 |
|
|
2020
Q2 | $3.95M | Sell |
40,192
-429
| -1% | -$42.1K | 3.35% | 5 |
|
|
2020
Q1 | $3.1M | Buy |
40,621
+5,984
| +17% | +$456K | 3.22% | 6 |
|
|
2019
Q4 | $3.07M | Buy |
+34,637
| New | +$3.07M | 2.56% | 8 |
|